These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1559227)

  • 41. Reduced or absent expression and codon 201Gly/Arg polymorphism of DCC gene in rhabdomyosarcoma and Ewing's sarcoma/PNET family.
    Choi SH; Kong XT; Taki T; Tsuchida Y; Kawaguchi H; Kato H; Hanada R; Look AT; Hayashi Y
    Int J Mol Med; 2000 Oct; 6(4):463-7. PubMed ID: 10998440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.
    Diller L; Sexsmith E; Gottlieb A; Li FP; Malkin D
    J Clin Invest; 1995 Apr; 95(4):1606-11. PubMed ID: 7706467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutation analysis of p53 gene in childhood malignant solid tumors.
    Kusafuka T; Fukuzawa M; Oue T; Komoto Y; Yoneda A; Okada A
    J Pediatr Surg; 1997 Aug; 32(8):1175-80. PubMed ID: 9269965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma.
    McIntyre JF; Smith-Sorensen B; Friend SH; Kassell J; Borresen AL; Yan YX; Russo C; Sato J; Barbier N; Miser J
    J Clin Oncol; 1994 May; 12(5):925-30. PubMed ID: 8164043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas.
    Nakamura T; Yana I; Kobayashi T; Shin E; Karakawa K; Fujita S; Miya A; Mori T; Nishisho I; Takai S
    Jpn J Cancer Res; 1992 Dec; 83(12):1293-8. PubMed ID: 1483945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines.
    Kim JH; Takahashi T; Chiba I; Park JG; Birrer MJ; Roh JK; De Lee H; Kim JP; Minna JD; Gazdar AF
    J Natl Cancer Inst; 1991 Jul; 83(13):938-43. PubMed ID: 1676761
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p53 protein accumulation and gene mutations in human glioma cell lines.
    Anker L; Ohgaki H; Ludeke BI; Herrmann HD; Kleihues P; Westphal M
    Int J Cancer; 1993 Dec; 55(6):982-7. PubMed ID: 8253536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors.
    Würl P; Taubert H; Bache M; Kroll J; Meye A; Berger D; Siermann A; Holzhausen HJ; Hinze R; Schmidt H; Rath FW
    Int J Cancer; 1996 Aug; 69(4):317-23. PubMed ID: 8797875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. P53 mutations are infrequent and do not correlate with the metastatic potential of human-melanoma cells.
    Luca M; Lenzi R; Leejackson D; Gutman M; Fidler I; Bareli M
    Int J Oncol; 1993 Jul; 3(1):19-22. PubMed ID: 21573319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p53 gene mutations in Chinese human testicular seminoma.
    Ye DW; Zheng J; Qian SX; Ma Y; Zheng X; Li D; Gu S
    J Urol; 1993 Sep; 150(3):884-6. PubMed ID: 8345605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The detection of mutations induced in vitro in the human p53 gene by hydrogen peroxide with the restriction site mutation (RSM) assay.
    Jenkins GJ; Morgan C; Baxter JN; Parry EM; Parry JM
    Mutat Res; 2001 Nov; 498(1-2):135-44. PubMed ID: 11673079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of p53 gene mutations in rat hepatocellular carcinoma cell lines by denaturing gradient gel electrophoresis.
    Fukuda I; Ogawa K
    Mol Carcinog; 1993; 7(4):257-62. PubMed ID: 8352884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic alteration of p53 in some patients with adult T-cell leukemia.
    Nagai H; Kinoshita T; Imamura J; Murakami Y; Hayashi K; Mukai K; Ikeda S; Tobinai K; Saito H; Shimoyama M
    Jpn J Cancer Res; 1991 Dec; 82(12):1421-7. PubMed ID: 1778765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p53 gene mutations in pediatric brain tumors.
    Felix CA; Slavc I; Dunn M; Strauss EA; Phillips PC; Rorke LB; Sutton L; Bunin GR; Biegel JA
    Med Pediatr Oncol; 1995 Dec; 25(6):431-6. PubMed ID: 7565304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutational analysis of the human p53 gene in malignant melanoma.
    Volkenandt M; Schlegel U; Nanus DM; Albino AP
    Pigment Cell Res; 1991 Feb; 4(1):35-40. PubMed ID: 1924172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemi- or homozygosity: a requirement for some but not other p53 mutant proteins to accumulate and exert a pathogenetic effect.
    Bhatia K; Goldschmidts W; Gutierrez M; Gaidano G; Dalla-Favera R; Magrath I
    FASEB J; 1993 Jul; 7(10):951-6. PubMed ID: 8344493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A de novo p53 germline mutation affecting codon 151 in a six year old child with multiple tumors.
    Gutiérrez MI; Bhatia KG; Barreiro C; Spangler G; Schvartzmann E; Muriel FS; Magrath IT
    Hum Mol Genet; 1994 Dec; 3(12):2247-8. PubMed ID: 7881428
    [No Abstract]   [Full Text] [Related]  

  • 58. Low frequency of the p53 gene mutations in neuroblastoma.
    Hosoi G; Hara J; Okamura T; Osugi Y; Ishihara S; Fukuzawa M; Okada A; Okada S; Tawa A
    Cancer; 1994 Jun; 73(12):3087-93. PubMed ID: 8200007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A mutational hot spot in the p53 gene is associated with hepatoblastomas.
    Oda H; Nakatsuru Y; Imai Y; Sugimura H; Ishikawa T
    Int J Cancer; 1995 Mar; 60(6):786-90. PubMed ID: 7896446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. P53 gene mutations in pleuropulmonary blastomas.
    Kusafuka T; Kuroda S; Inoue M; Ara T; Yoneda A; Oue T; Udatsu Y; Osugi Y; Okada A
    Pediatr Hematol Oncol; 2002 Mar; 19(2):117-28. PubMed ID: 11881786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.